References
- Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic map using sparse gene flow trees. Nat Genet 2002; 30: 97–101
- Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y. Association of a C/T single- nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with Graves’ disease in Japanese. Thyroid 2006; 16: 443–446
- Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, Abid M, Ayadi H. CTLA-4 gene polymorphisms in Tunisian patients with Graves’ disease. Clin Immunol 2001; 101: 361–365
- Hadj Kacem H, Rebaï A, Kaffel N, Masmoudi S, Abid M, Ayadi H. PDS is a new susceptibility gene to autoimmune thyroid diseases: Association and linkage study. J Clin Endocrinol Metab 2003; 88: 2274–2280
- Haynes C, Blach C. Database design for gene mapping studies. Approaches to gene mapping in complex human diseases, Haines JL, Pericak-Vance MA. Wiley-Liss, New York 1998; 247
- Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, Gough CL. A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves’ disease in UK Caucasians. Clin Endocrinol 2004; 6: 269–272
- Houston FA, Wilson V, Jennings CE, Owen CJ, Donaldson P, Perros P, Pearce SHS. Role of the CD40 locus in Graves’ disease. Thyroid 2004; 14: 506–509
- Jacobson EM, Concepcion E, Oashi T, Tomer Y. A Graves’ disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: A case for translational pathophysiology. Endocrinology 2005; 6: 2684–2691
- Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY, Park DJ. A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves’ disease in Koreans. Thyroid 2003; 13: 919–925
- Kurylowicz A, Kula D, Ploski R, Skorka A, Jurecka-Lubieniecka B, Zebracka J, Steinhof-Radwanska K, Hass-Lazar K, Hiromatsu Y, Jarzab B, et al. Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype Graves’ disease. Thyroid 2005; 15: 1119–1123
- Laird NM, Horvath S, Xu X. Implementing a unified approach to family-based tests of association. Genet Epidemiol 2000; 19: S36–S42
- Maalej A, Bougacha N, Rebai A, Bellassouad M, Ayadi-Makni F, Abid M, Jouida J, Makni H, Ayadi H. Lack of linkage and association between autoimmune thyroid diseases and the CTLA-4 gene in a large Tunisian family. Hum Immunol 2001a; 62: 1245–1250
- Maalej A, Makni H, Ayadi F, Bellassoued M, Jouida J, Bouguacha N, Abid M, Ayadi H. A full genome screening in a large Tunisian family affected with thyroid autoimmune disorders. Genes Immun 2001b; 2: 71–75
- Makni H, Maalej A, Ayadi F, Abid M, Jouida J, Ayadi H. Clinical and biological follow up of a family with high prevalence of thyroid autoimmune disease. Tunisie Medicale 1996; 74: 433–438
- Mukai T, Hiromatsu Y, Fukutani T, Ichimura M, Kaku H, Miyake I, Yamada K. A C/T polymorphism in the 5′ÿ untranslated region of the CD40 gene is associated with later onset of Graves’ disease in Japanese. Endocr J 2005; 52: 471–477
- Pearce SHS, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P. Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves’ disease. Am J Hum Genet 1999; 65: 1462–1465
- Tomer Y, Barbesino G, Greenberg DA, Concepcion E, Davies TF. A new Graves’ disease-susceptibility locus maps to chromosome 20q11.2. Am J Hum Genet 1998; 63: 1749–1756
- Tomer Y, Concepcion E, Greenberg DA. A C/T Single-Nucleotide Polymorphism in the region of the CD40 gene is associated with Graves’ disease. Thyroid 2002; 12: 1129–1135
- Tomer Y, Davies TF, Greenberg DA. What is the contribution of a Kozak SNP in the CD40 gene to Graves’ disease?. Clin Endocrinol 2005; 62: 258